Nrc Health (NRC) Liabilities and Shareholders Equity (2010 - 2026)

Nrc Health has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $134.6 million for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $134.6 million, changed 0.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $546.5 million (up 5.39% YoY), and the FY2025 annual result was $134.9 million, up 1.76% from the prior year.
• Liabilities and Shareholders Equity came in at $134.6 million for Q1 2026 at Nrc Health, roughly flat from $134.9 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $153.2 million in Q1 2022 to a low of $119.1 million in Q2 2024.
• The 5-year median for Liabilities and Shareholders Equity is $134.3 million (2023), against an average of $132.4 million.
• Across the five-year window, Liabilities and Shareholders Equity fell 17.19% in 2022 and climbed 18.71% in 2025, its largest moves.
• Nrc Health's Liabilities and Shareholders Equity stood at $130.5 million in 2022, then declined by 6.15% to $122.4 million in 2023, then grew by 8.25% to $132.5 million in 2024, then gained by 1.76% to $134.9 million in 2025, then slipped by 0.24% to $134.6 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $134.6 million (Q1 2026), $134.9 million (Q4 2025), and $135.7 million (Q3 2025), per Business Quant data.